ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 138 filers reported holding ACCELERON PHARMA INC in Q2 2016. The put-call ratio across all filers is 6.11 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $667,000 | -92.6% | 7,000 | -96.9% | 0.06% | -96.1% |
Q3 2019 | $8,992,000 | -18.7% | 227,596 | -15.5% | 1.55% | +17.2% |
Q2 2019 | $11,067,000 | -11.8% | 269,396 | 0.0% | 1.32% | -12.3% |
Q1 2019 | $12,546,000 | +36.1% | 269,396 | +27.2% | 1.51% | +20.4% |
Q4 2018 | $9,221,000 | -46.1% | 211,726 | -29.1% | 1.25% | -31.0% |
Q3 2018 | $17,096,000 | +14.9% | 298,726 | -2.6% | 1.82% | +9.1% |
Q2 2018 | $14,877,000 | +69.7% | 306,626 | +36.7% | 1.66% | +73.0% |
Q1 2018 | $8,767,000 | -71.0% | 224,226 | -68.5% | 0.96% | -74.6% |
Q4 2017 | $30,232,000 | +33.9% | 712,356 | +17.8% | 3.78% | +29.9% |
Q3 2017 | $22,577,000 | +22.9% | 604,957 | +0.1% | 2.91% | +44.7% |
Q2 2017 | $18,371,000 | +449.0% | 604,499 | +378.2% | 2.01% | +413.8% |
Q1 2017 | $3,346,000 | -62.0% | 126,400 | -63.4% | 0.39% | -59.9% |
Q4 2016 | $8,810,000 | -49.5% | 345,225 | -28.3% | 0.98% | -43.0% |
Q3 2016 | $17,435,000 | -1.8% | 481,765 | -7.8% | 1.71% | -6.7% |
Q2 2016 | $17,748,000 | -53.2% | 522,294 | -63.7% | 1.83% | -0.1% |
Q1 2016 | $37,929,000 | -30.6% | 1,437,235 | +28.2% | 1.83% | -21.3% |
Q4 2015 | $54,673,000 | +258.7% | 1,121,264 | +83.2% | 2.33% | +234.0% |
Q3 2015 | $15,243,000 | -26.1% | 612,184 | -6.1% | 0.70% | -18.9% |
Q2 2015 | $20,632,000 | -9.5% | 652,084 | +8.8% | 0.86% | -0.6% |
Q1 2015 | $22,805,000 | -18.0% | 599,184 | -16.1% | 0.87% | -30.6% |
Q4 2014 | $27,817,000 | +26.6% | 713,995 | -1.7% | 1.25% | +35.1% |
Q3 2014 | $21,967,000 | +9.8% | 726,424 | +23.3% | 0.92% | +9.0% |
Q2 2014 | $20,010,000 | +5044.0% | 589,053 | +5894.2% | 0.85% | +4888.2% |
Q4 2013 | $389,000 | – | 9,827 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |